
### [MONDO:0019238](http://purl.obolibrary.org/obo/MONDO_0019238)
**Label:** inborn disorder of pyrimidine metabolism

**Subclasses:** [MONDO:0009111](http://purl.obolibrary.org/obo/MONDO_0009111) (dihydropyrimidinuria), [MONDO:0013164](http://purl.obolibrary.org/obo/MONDO_0013164) (beta-ureidopropionase deficiency), [MONDO:0010130](http://purl.obolibrary.org/obo/MONDO_0010130) (dihydropyrimidine dehydrogenase deficiency), [MONDO:0017575](http://purl.obolibrary.org/obo/MONDO_0017575) (mitochondrial neurogastrointestinal encephalomyopathy), [MONDO:0009378](http://purl.obolibrary.org/obo/MONDO_0009378) (hyper-beta-alaninemia), [MONDO:0009797](http://purl.obolibrary.org/obo/MONDO_0009797) (orotic aciduria), [MONDO:0012301](http://purl.obolibrary.org/obo/MONDO_0012301) (mitochondrial dna depletion syndrome, myopathic form), [MONDO:0014647](http://purl.obolibrary.org/obo/MONDO_0014647) (CAD-CDG), [MONDO:0009946](http://purl.obolibrary.org/obo/MONDO_0009946) (hemolytic anemia due to pyrimidine 5' nucleotidase deficiency), 

**Mapped go classes:** [GO:0019483](http://purl.obolibrary.org/obo/GO_0019483) (beta-alanine biosynthetic process), [GO:0030947](http://purl.obolibrary.org/obo/GO_0030947) (regulation of vascular endothelial growth factor receptor signaling pathway), [GO:0019482](http://purl.obolibrary.org/obo/GO_0019482) (beta-alanine metabolic process), [GO:0005506](http://purl.obolibrary.org/obo/GO_0005506) (iron ion binding), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0043195](http://purl.obolibrary.org/obo/GO_0043195) (terminal bouton), [GO:0019240](http://purl.obolibrary.org/obo/GO_0019240) (citrulline biosynthetic process), [GO:0071897](http://purl.obolibrary.org/obo/GO_0071897) (DNA biosynthetic process), [GO:0001946](http://purl.obolibrary.org/obo/GO_0001946) (lymphangiogenesis), [GO:0016757](http://purl.obolibrary.org/obo/GO_0016757) (transferase activity, transferring glycosyl groups), [GO:0008593](http://purl.obolibrary.org/obo/GO_0008593) (regulation of Notch signaling pathway), [GO:0004151](http://purl.obolibrary.org/obo/GO_0004151) (dihydroorotase activity), [GO:0032042](http://purl.obolibrary.org/obo/GO_0032042) (mitochondrial DNA metabolic process), [GO:0051260](http://purl.obolibrary.org/obo/GO_0051260) (protein homooligomerization), [GO:0006212](http://purl.obolibrary.org/obo/GO_0006212) (uracil catabolic process), [GO:0004152](http://purl.obolibrary.org/obo/GO_0004152) (dihydroorotate dehydrogenase activity), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0006210](http://purl.obolibrary.org/obo/GO_0006210) (thymine catabolic process), [GO:0014070](http://purl.obolibrary.org/obo/GO_0014070) (response to organic cyclic compound), [GO:0046104](http://purl.obolibrary.org/obo/GO_0046104) (thymidine metabolic process), [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex), [GO:0004157](http://purl.obolibrary.org/obo/GO_0004157) (dihydropyrimidinase activity), [GO:0044205](http://purl.obolibrary.org/obo/GO_0044205) ('de novo' UMP biosynthetic process), [GO:0004159](http://purl.obolibrary.org/obo/GO_0004159) (dihydrouracil dehydrogenase (NAD+) activity), [GO:0004797](http://purl.obolibrary.org/obo/GO_0004797) (thymidine kinase activity), [GO:0002134](http://purl.obolibrary.org/obo/GO_0002134) (UTP binding), [GO:0006214](http://purl.obolibrary.org/obo/GO_0006214) (thymidine catabolic process), [GO:0006208](http://purl.obolibrary.org/obo/GO_0006208) (pyrimidine nucleobase catabolic process), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0006207](http://purl.obolibrary.org/obo/GO_0006207) ('de novo' pyrimidine nucleobase biosynthetic process), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0016363](http://purl.obolibrary.org/obo/GO_0016363) (nuclear matrix), [GO:0051539](http://purl.obolibrary.org/obo/GO_0051539) (4 iron, 4 sulfur cluster binding), [GO:0051536](http://purl.obolibrary.org/obo/GO_0051536) (iron-sulfur cluster binding), [GO:0016627](http://purl.obolibrary.org/obo/GO_0016627) (oxidoreductase activity, acting on the CH-CH group of donors), [GO:0006145](http://purl.obolibrary.org/obo/GO_0006145) (purine nucleobase catabolic process), [GO:0006541](http://purl.obolibrary.org/obo/GO_0006541) (glutamine metabolic process), [GO:0004087](http://purl.obolibrary.org/obo/GO_0004087) (carbamoyl-phosphate synthase (ammonia) activity), [GO:0048812](http://purl.obolibrary.org/obo/GO_0048812) (neuron projection morphogenesis), [GO:0006264](http://purl.obolibrary.org/obo/GO_0006264) (mitochondrial DNA replication), [GO:0004088](http://purl.obolibrary.org/obo/GO_0004088) (carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0002059](http://purl.obolibrary.org/obo/GO_0002059) (thymine binding), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0000287](http://purl.obolibrary.org/obo/GO_0000287) (magnesium ion binding), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0046085](http://purl.obolibrary.org/obo/GO_0046085) (adenosine metabolic process), [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity), [GO:0001889](http://purl.obolibrary.org/obo/GO_0001889) (liver development), [GO:0019860](http://purl.obolibrary.org/obo/GO_0019860) (uracil metabolic process), [GO:0016597](http://purl.obolibrary.org/obo/GO_0016597) (amino acid binding), [GO:0016874](http://purl.obolibrary.org/obo/GO_0016874) (ligase activity), [GO:0071949](http://purl.obolibrary.org/obo/GO_0071949) (FAD binding), [GO:0009262](http://purl.obolibrary.org/obo/GO_0009262) (deoxyribonucleotide metabolic process), [GO:0021644](http://purl.obolibrary.org/obo/GO_0021644) (vagus nerve morphogenesis), [GO:0004137](http://purl.obolibrary.org/obo/GO_0004137) (deoxycytidine kinase activity), [GO:0005743](http://purl.obolibrary.org/obo/GO_0005743) (mitochondrial inner membrane), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0000050](http://purl.obolibrary.org/obo/GO_0000050) (urea cycle), [GO:0003837](http://purl.obolibrary.org/obo/GO_0003837) (beta-ureidopropionase activity), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0046092](http://purl.obolibrary.org/obo/GO_0046092) (deoxycytidine metabolic process), [GO:0016743](http://purl.obolibrary.org/obo/GO_0016743) (carboxyl- or carbamoyltransferase activity), [GO:0021636](http://purl.obolibrary.org/obo/GO_0021636) (trigeminal nerve morphogenesis), [GO:0060041](http://purl.obolibrary.org/obo/GO_0060041) (retina development in camera-type eye), [GO:0009116](http://purl.obolibrary.org/obo/GO_0009116) (nucleoside metabolic process), [GO:0046777](http://purl.obolibrary.org/obo/GO_0046777) (protein autophosphorylation), [GO:0006520](http://purl.obolibrary.org/obo/GO_0006520) (cellular amino acid metabolic process), [GO:0043025](http://purl.obolibrary.org/obo/GO_0043025) (neuronal cell body), [GO:0004588](http://purl.obolibrary.org/obo/GO_0004588) (orotate phosphoribosyltransferase activity), [GO:0009117](http://purl.obolibrary.org/obo/GO_0009117) (nucleotide metabolic process), [GO:0051289](http://purl.obolibrary.org/obo/GO_0051289) (protein homotetramerization), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0017144](http://purl.obolibrary.org/obo/GO_0017144) (drug metabolic process), [GO:0051607](http://purl.obolibrary.org/obo/GO_0051607) (defense response to virus), [GO:0019206](http://purl.obolibrary.org/obo/GO_0019206) (nucleoside kinase activity), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0004070](http://purl.obolibrary.org/obo/GO_0004070) (aspartate carbamoyltransferase activity), [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process), [GO:0004590](http://purl.obolibrary.org/obo/GO_0004590) (orotidine-5'-phosphate decarboxylase activity), [GO:0007584](http://purl.obolibrary.org/obo/GO_0007584) (response to nutrient), [GO:0007623](http://purl.obolibrary.org/obo/GO_0007623) (circadian rhythm), [GO:0006139](http://purl.obolibrary.org/obo/GO_0006139) (nucleobase-containing compound metabolic process), [GO:1900746](http://purl.obolibrary.org/obo/GO_1900746) (regulation of vascular endothelial growth factor signaling pathway), [GO:0002058](http://purl.obolibrary.org/obo/GO_0002058) (uracil binding), [GO:0006526](http://purl.obolibrary.org/obo/GO_0006526) (arginine biosynthetic process), [GO:0006807](http://purl.obolibrary.org/obo/GO_0006807) (nitrogen compound metabolic process), [GO:0051219](http://purl.obolibrary.org/obo/GO_0051219) (phosphoprotein binding), [GO:0018107](http://purl.obolibrary.org/obo/GO_0018107) (peptidyl-threonine phosphorylation), [GO:0021615](http://purl.obolibrary.org/obo/GO_0021615) (glossopharyngeal nerve morphogenesis), [GO:0006222](http://purl.obolibrary.org/obo/GO_0006222) (UMP biosynthetic process), [GO:0016829](http://purl.obolibrary.org/obo/GO_0016829) (lyase activity), [GO:0042594](http://purl.obolibrary.org/obo/GO_0042594) (response to starvation), [GO:0045984](http://purl.obolibrary.org/obo/GO_0045984) (negative regulation of pyrimidine nucleobase metabolic process), [GO:0021610](http://purl.obolibrary.org/obo/GO_0021610) (facial nerve morphogenesis), [GO:0006221](http://purl.obolibrary.org/obo/GO_0006221) (pyrimidine nucleotide biosynthetic process), [GO:0042995](http://purl.obolibrary.org/obo/GO_0042995) (cell projection), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0032868](http://purl.obolibrary.org/obo/GO_0032868) (response to insulin), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0016831](http://purl.obolibrary.org/obo/GO_0016831) (carboxy-lyase activity), [GO:0016810](http://purl.obolibrary.org/obo/GO_0016810) (hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0016812](http://purl.obolibrary.org/obo/GO_0016812) (hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0008253](http://purl.obolibrary.org/obo/GO_0008253) (5'-nucleotidase activity), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0050661](http://purl.obolibrary.org/obo/GO_0050661) (NADP binding), [GO:0006228](http://purl.obolibrary.org/obo/GO_0006228) (UTP biosynthetic process), [GO:0042493](http://purl.obolibrary.org/obo/GO_0042493) (response to drug), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0017113](http://purl.obolibrary.org/obo/GO_0017113) (dihydropyrimidine dehydrogenase (NADP+) activity), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), [GO:0019899](http://purl.obolibrary.org/obo/GO_0019899) (enzyme binding), 

**Class expressions from DL-Learner:**

- Thing 54.19%
- [GO:0002061](http://purl.obolibrary.org/obo/GO_0002061) (pyrimidine nucleobase binding) 52.33%
- [GO:0071949](http://purl.obolibrary.org/obo/GO_0071949) (FAD binding) 51.16%
- [GO:0051539](http://purl.obolibrary.org/obo/GO_0051539) (4 iron, 4 sulfur cluster binding) 51.16%
- [GO:0050660](http://purl.obolibrary.org/obo/GO_0050660) (flavin adenine dinucleotide binding) 51.16%
- [GO:0032557](http://purl.obolibrary.org/obo/GO_0032557) (pyrimidine ribonucleotide binding) 51.16%
- [GO:0032551](http://purl.obolibrary.org/obo/GO_0032551) (pyrimidine ribonucleoside binding) 51.16%
- [GO:0019103](http://purl.obolibrary.org/obo/GO_0019103) (pyrimidine nucleotide binding) 51.16%
- [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding) 51.16%
- [GO:0002134](http://purl.obolibrary.org/obo/GO_0002134) (UTP binding) 51.16%
- [GO:0002059](http://purl.obolibrary.org/obo/GO_0002059) (thymine binding) 51.16%
- [GO:0002058](http://purl.obolibrary.org/obo/GO_0002058) (uracil binding) 51.16%
- [GO:0001884](http://purl.obolibrary.org/obo/GO_0001884) (pyrimidine nucleoside binding) 51.16%
- [GO:0002061](http://purl.obolibrary.org/obo/GO_0002061) (pyrimidine nucleobase binding) and [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) 51.16%
- [GO:0002054](http://purl.obolibrary.org/obo/GO_0002054) (nucleobase binding) and [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) 51.16%


